TY - JOUR AU - Addeo, Alfredo AU - Banna, Giuseppe Luigi PY - 2018 TI - PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer? JF - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research<sup>1</sup> Y2 - 2018 KW - N2 - We have read with great interest our Colleagues’ point of view suggesting that immunotherapy should not be integrated into the treatment of oncogene-driven non-small cell lung cancers (NSCLCs) based on currently available evidence. However, we would like to mention three points to challenge their recommendation. UR - https://tlcr.amegroups.org/article/view/23044